Equities

Nouveau Life Pharmaceuticals Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
NOUV:PKL

Nouveau Life Pharmaceuticals Inc

Actions
  • Price (USD)0.000001
  • Today's Change0.00 / 0.00%
  • Shares traded526.00k
  • 1 Year change-99.00%
  • Beta--
Data delayed at least 15 minutes, as of Feb 10 2026 20:07 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Nouveau Life Pharmaceuticals, Inc. is a Canada-based company, which provides an A Platform for Remote Senior Care. With the NOUV platform, they can monitor all of their patients at a glance. It also provides to monitor details of each patient by just clicking on them. In the case of an emergency, NOUV will detect it before they do. The Company is also focused on its robotic and Ai-based healthcare devices and wearables. Its applications include NOUV Friends - for Seniors, NOUV Guardian - for Individual Personal Users, and NOUV Care Guardian - for Organization. Its subsidiary is Seniorgo.ai.

  • Revenue in USD (TTM)0.00
  • Net income in USD-504.00k
  • Incorporated1998
  • Employees0.00
  • Location
    Nouveau Life Pharmaceuticals Inc237 Main Street, Box 880NIVERVILLE R0A 1E0CanadaCAN
  • Phone+1 (888) 550-2333
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nouveau Life Pharmaceuticals Inc0.00-504.00k6.66k0.00--0.0001-----0.0168-0.01680.000.00880.00-------39.38---110.89-------------4.200.5507-------38.91------
Data as of Feb 10 2026. Currency figures normalised to Nouveau Life Pharmaceuticals Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.